GoAI
立即開始
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc.

NDRA

NASDAQHealthcareMedical - Diagnostics & Research

在 GoAI 中打開

前收盤價

US$4.49

−US$0.095 · -2.07%

8月21日 下午4:00 ET

NDRA公司概覽

盤中時間採用ET。市場資料可能有所延遲。

GoAI 研究快照

簡明呈現最新可用的模型資訊。

2026年7月10日

GoAI評分

Sell

Trim exposure — unfavorable risk-reward

估值

25

Expensive

動能

77

Gaining

情緒

52

Mixed

風險韌性

38

High Risk

完整 GoAI 研究

繼續查看更深入的依據、催化因素和風險。

看完整研究

人工智慧產生的上下文僅供參考，並非投資建議。

公司概況

公司網站

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.

產業
Medical - Diagnostics & Research
部門
Healthcare
總部
US
執行長
Alexander Y. Tokman
上市以來
2017年6月30日
僱員
10

市場位置

日內區間

目前US$4.49，

52週區間

目前US$4.49，

開盤價
US$4.63
前收盤價
US$4.585
成交量
2.73萬
0.99× 平均值
平均成交量
2.74萬
日均成交量
市值
570.26萬 USD
貝塔
-0.07
市場參考 1
50天平均值
US$4.8531
低於平均水平-7.48%
200天平均值
US$4.7807
低於平均水平-6.08%

財務數據

財務快照

最近十二個月

估值與收益率

企業價值
329.52萬 USD
本益比（TTM）
-0.71×
股價淨值比（TTM）
0.94×
股價營收比（TTM）
0×
EV/EBITDA
-0.48×
盈餘收益率
-197.11%
自由現金流收益率
-145.85%
股息率
0.00%

獲利能力和效率

毛利率
0.00%
營業利益率
0.00%
淨利潤率
0.00%
股東權益報酬率
-310.93%
資產報酬率
-182.35%
投入資本報酬率
-178.30%

財務健康

負債權益比
0.07×
流動比率
1.29×

財務報表

損益趨勢

營業利益

−576.31萬 USD+46.72%

淨利

−702.74萬 USD+38.93%
損益趨勢 圖表−502.15萬 USD−798.79萬 USD−1095.43萬 USD−1392.07萬 USD營業利益，2021會計年度：−1149.83萬 USD營業利益，2022會計年度：−1315.76萬 USD營業利益，2023會計年度：−1052.07萬 USD營業利益，2024會計年度：−1081.71萬 USD營業利益，2025會計年度：−576.31萬 USD淨利，2021會計年度：−1123.13萬 USD淨利，2022會計年度：−1317.91萬 USD淨利，2023會計年度：−1006.03萬 USD淨利，2024會計年度：−1150.79萬 USD淨利，2025會計年度：−702.74萬 USD2021會計年度2022會計年度2023會計年度2024會計年度2025會計年度
2021會計年度的營業利益為−1149.83萬 USD。 2022會計年度的營業利益為−1315.76萬 USD。 2023會計年度的營業利益為−1052.07萬 USD。 2024會計年度的營業利益為−1081.71萬 USD。 2025會計年度的營業利益為−576.31萬 USD。 2021會計年度的淨利為−1123.13萬 USD。 2022會計年度的淨利為−1317.91萬 USD。 2023會計年度的淨利為−1006.03萬 USD。 2024會計年度的淨利為−1150.79萬 USD。 2025會計年度的淨利為−702.74萬 USD。
項目（USD）2025會計年度2024會計年度2023會計年度2022會計年度2021會計年度
研究與開發185萬 USD319.03萬 USD500.37萬 USD655.42萬 USD548.25萬 USD
銷售、一般及管理費用391.31萬 USD762.69萬 USD551.7萬 USD660.34萬 USD601.58萬 USD
營業費用576.31萬 USD1081.71萬 USD1052.07萬 USD1315.76萬 USD1149.83萬 USD
利息支出———2.15萬 USD—
折舊和攤銷15.73萬 USD20.62萬 USD27.55萬 USD23.43萬 USD22.44萬 USD
營業利益−576.31萬 USD−1081.71萬 USD−1052.07萬 USD−1315.76萬 USD−1149.83萬 USD
淨利−702.74萬 USD−1150.79萬 USD−1006.03萬 USD−1317.91萬 USD−1123.13萬 USD

公司資料更新於 2026年8月24日。

NDRA 訊息

businesswire.com

ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver…

閱讀原始碼
globenewswire.com

ASP Isotopes Issues Letter to Shareholders

DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of…

閱讀原始碼
businesswire.com

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or “ASPI”), an advanced materials company focused on developing technologies and processes for the production…

閱讀原始碼
accessnewswire.com

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

Noble Africa was created to unlock the value of Renergen's Virginia Gas Project through a public company focused on helium and LNG Learn why the Virginia Gas Project is positioned to become one of the world's most…

閱讀原始碼
globenewswire.com

Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

閱讀原始碼
gurufocus.com

NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ENDRA Life Sciences Inc. (NASDAQ: NDRA) with Noble Africa LLC. Upon closing of the

閱讀原始碼

NDRA同業公司

Amgen Inc. logo

AMGN

Amgen Inc.

US$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

US$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

US$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

US$378.81

+1.16%

Sanofi logo

SNY

Sanofi

US$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

US$834.04

+0.90%

持有NDRA的ETF

報告持有此股票曝險的交易所交易基金。

Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
市場價值
3.5萬
重量
0.00%
AUM
937億 USD
費用率
0.05%
價格 / 1日
US$245.53+0.82%

繼續GoAI的研究

在 GoAI 中研究NDRA

research.disclaimer